GlaxoSmithKline PLC banner

GlaxoSmithKline PLC
LSE:GSK

Watchlist Manager
GlaxoSmithKline PLC Logo
GlaxoSmithKline PLC
LSE:GSK
Watchlist
Price: 2 023 GBX -0.74%
Market Cap: £82.5B

Wall Street
Price Targets

GSK Price Targets Summary
GlaxoSmithKline PLC

Wall Street analysts forecast GSK stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GSK is 2 038.47 GBX with a low forecast of 1 469.55 GBX and a high forecast of 2 740.5 GBX.

Lowest
Price Target
1 469.55 GBX
27% Downside
Average
Price Target
2 038.47 GBX
1% Upside
Highest
Price Target
2 740.5 GBX
35% Upside
GlaxoSmithKline PLC Competitors:
Price Targets
OFN
Orell Fuessli AG
-1% Downside

Revenue
Forecast

1% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
1% / Year
Past Growth
5% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

For the last 14 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 1%. The projected CAGR for the next 3 years is 5%.

Operating Income
Forecast

1% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss
1% / Year
Past Growth
7% / Year
Estimated Growth
Estimates Accuracy
-6%
Average Miss

For the last 14 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 1%. The projected CAGR for the next 3 years is 7%.

Net Income
Forecast

1% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss
1% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-23%
Average Miss

For the last 14 years the compound annual growth rate for GlaxoSmithKline PLC's net income is 1%. The projected CAGR for the next 3 years is 14%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GSK's stock price target?
Price Target
2 038.47 GBX

According to Wall Street analysts, the average 1-year price target for GSK is 2 038.47 GBX with a low forecast of 1 469.55 GBX and a high forecast of 2 740.5 GBX.

What is GlaxoSmithKline PLC's Revenue forecast?
Projected CAGR
5%

For the last 14 years the compound annual growth rate for GlaxoSmithKline PLC's revenue is 1%. The projected CAGR for the next 3 years is 5%.

What is GlaxoSmithKline PLC's Operating Income forecast?
Projected CAGR
7%

For the last 14 years the compound annual growth rate for GlaxoSmithKline PLC's operating income is 1%. The projected CAGR for the next 3 years is 7%.

What is GlaxoSmithKline PLC's Net Income forecast?
Projected CAGR
14%

For the last 14 years the compound annual growth rate for GlaxoSmithKline PLC's net income is 1%. The projected CAGR for the next 3 years is 14%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett